Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23835, expectations were $-0.28. Aclaris Therapeutics, Inc.
Posts Tagged ‘NASDAQ:ACRS’
5 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at five cheap small cap stocks to buy before the next breakout.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Aclaris Therapeutics First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Did Hedge Funds Catch A Break With Aclaris Therapeutics, Inc. (ACRS)?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file ...
Is Aclaris Therapeutics, Inc. (ACRS) Going to Burn These Hedge Funds?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
5 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners
In this article, we discuss the 5 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
Hedge Funds Are Crazy About Aclaris Therapeutics, Inc. (ACRS)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
5 Best Small-Cap Stocks to Buy According to Hedge Funds
In this article, we discuss the 5 best small-cap stocks to buy according to hedge funds.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we will discuss the 10 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Hedge Funds Have Never Been This Bullish On Aclaris Therapeutics, Inc. (ACRS)
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Is ACRS A Good Stock To Buy Now?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus talks, many smart money investors ...
Hedge Funds Are Buying Aclaris Therapeutics, Inc. (ACRS)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Is Aclaris Therapeutics, Inc. (ACRS) A Good Stock To Buy?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Did Hedge Funds Drop The Ball On Aclaris Therapeutics, Inc. (ACRS) ?
Is Aclaris Therapeutics, Inc.
Here’s What Hedge Funds Think About Aclaris Therapeutics, Inc. (ACRS)
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Do Hedge Funds Love Aclaris Therapeutics, Inc. (ACRS)?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
Hedge Fund and Insider Trading News: Carl Icahn, Adage Capital Management, Pierre Andurand, Simpson Manufacturing Co, Inc. (SSD), Evans & Sutherland (ESCC), William Lyon Homes (WLH), and More
(Reuters) - SandRidge Energy Inc (SD.N) yielded to demands from top shareholder Carl Icahn on Monday and said it would evaluate any buyout offers, including one promised last ...
13G Filing: James E. Flynn and Aclaris Therapeutics Inc (ACRS)
Please follow Deerfield Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Deerfield Management or update its stock...
Aclaris Therapeutics Inc (ACRS) Hedge Funds Are Snapping Up
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Aclaris Therapeutics Inc (ACRS): RA Capital Management Disposes of 1.1 Million Shares
An amended 13G filing with the SEC revealed that Peter Kolchinsky's RA Capital Management has sold around 1.1 million shares of Aclaris Therapeutics Inc (NASDAQ:ACRS), decreasing...
Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016
Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks.
Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors
Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare...
